Northpointe Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-34,261
| Closed | -$2.45M | – | 174 |
|
|
2017
Q4 | $2.45M | Buy |
+34,261
| New | +$2.45M | 0.28% | 150 |
|
|
2015
Q2 | – | Sell |
-18,463
| Closed | -$1.81M | – | 208 |
|
|
2015
Q1 | $1.81M | Sell |
18,463
-7,099
| -28% | -$697K | 0.2% | 162 |
|
|
2014
Q4 | $2.41M | Buy |
25,562
+2,212
| +9% | +$208K | 0.29% | 122 |
|
|
2014
Q3 | $2.49M | Buy |
23,350
+127
| +0.5% | +$13.5K | 0.26% | 112 |
|
|
2014
Q2 | $1.93M | Buy |
23,223
+9,493
| +69% | +$787K | 0.19% | 155 |
|
|
2014
Q1 | $972K | Buy |
+13,730
| New | +$972K | 0.1% | 195 |
|
|
2013
Q4 | – | Sell |
-12,743
| Closed | -$801K | – | 242 |
|
|
2013
Q3 | $801K | Buy |
12,743
+3,183
| +33% | +$200K | 0.09% | 198 |
|
|
2013
Q2 | $490K | Buy |
+9,560
| New | +$490K | 0.06% | 187 |
|